Health Canada’s chief medical advisor Dr. Supriya Sharma said Friday that Canadian manufacturers of children’s pain medication ramped up production to record levels, as they faced unprecedented demand amid a surge in influenza and RSV infections, alongside the COVID-19 pandemic. However, she said demand has still outstripped supply.
- N.L. children’s hospital cancels some surgeries amid surge in respiratory illness
- Kids’ pain meds: Canada to get 500K additional units in coming weeks
- Health Canada reviews RSV vaccine candidate as cases spike across country